Form 13-F position report

RITTER PHARMACEUTICALS INC

Reported by WELLS FARGO & COMPANY MN

RTTR CUSIP 767836109 Manager CIK 0000072971

Reported 0 shares, down 11,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2018
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 6 Through Q1 2018

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for RITTER PHARMACEUTICALS INC held by WELLS FARGO & COMPANY MN.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

19 managers reported RITTER PHARMACEUTICALS INC for Q1 2018.

Managers reporting RITTER PHARMACEUTICALS INC in Q1 2018.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ARMISTICE CAPITAL LLC Reduced 0 -1,900,000 0 $0 3 qtrs
CITADEL ADVISORS LLC Reduced 0 -113,697 0 $0 4 qtrs
WELLS FARGO & COMPANY MN This report Reduced 0 -11,000 0 $0 6 qtrs
UNITED CAPITAL FINANCIAL ADVISERS LLC Reduced 0 -40,000 0 $0 5 qtrs
Creative Planning Reduced 0 -95,600 0 $0 7 qtrs
TELEMUS CAPITAL LLC Reduced 0 -1,000 0 $0 2 qtrs
BAKER BROS ADVISORS LP Reduced 0 -2,800,000 0 $0 12 qtrs
BlackRock Inc Reduced 0 -82,919 0 $0 5 qtrs
THOMPSON DAVIS & CO INC Reduced 0 -9,000 0 $0 2 qtrs
ROYAL BANK OF CANADA Reduced 0 -12,000 0 $0 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2018
Filed
May 02, 2018
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.